tiprankstipranks
Trending News
More News >
Amicus Therapeutics (FOLD)
NASDAQ:FOLD
US Market

Amicus (FOLD) Technical Analysis

Compare
994 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
4Neutral
11Bearish
Technical Analysis Consensus
Sell
1Bullish
4Neutral
5Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Amicus Therapeutics’s (FOLD) Moving Averages Convergence Divergence (MACD) indicator is -0.39, suggesting Amicus Therapeutics is a Sell.
Amicus Therapeutics’s (FOLD) 20-Day exponential moving average is 7.31, while Amicus Therapeutics’s (FOLD) share price is $7.35, making it a Buy.
Amicus Therapeutics’s (FOLD) 50-Day exponential moving average is 8.07, while Amicus Therapeutics’s (FOLD) share price is $7.35, making it a Sell.

Amicus (FOLD) Pivot Points

Apr 26, 2025, 06:26 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.87
6.94
7.07
7.14
7.27
7.34
7.47
Fibonacci
6.94
7.02
7.06
7.14
7.22
7.26
7.34
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Amicus (FOLD) Moving Averages

Apr 26, 2025, 06:26 PM
Period
Simple
Exponential
MA5
7.05Buy
7.12Buy
MA10
6.89Buy
7.07Buy
MA20
7.21Buy
7.31Buy
MA50
8.33Sell
8.07Sell
MA100
8.98Sell
8.76Sell
MA200
9.93Sell
9.49Sell
Amicus Therapeutics’s (FOLD) 10-Day exponential moving average is 7.07, while Amicus Therapeutics’s (FOLD) share price is $7.35, making it a Buy.
Amicus Therapeutics’s (FOLD) 100-Day exponential moving average is 8.76, while Amicus Therapeutics’s (FOLD) share price is $7.35, making it a Sell.
Amicus Therapeutics’s (FOLD) stock price is $7.35 and Amicus Therapeutics’s (FOLD) 50-day simple moving average is 8.33, creating a Sell signal.
Amicus Therapeutics’s (FOLD) stock price is $7.35 and Amicus Therapeutics’s (FOLD) 100-day simple moving average is 8.98, creating a Sell signal.
Amicus Therapeutics’s (FOLD) stock price is $7.35 and Amicus Therapeutics’s (FOLD) 200-day simple moving average is 9.93, creating a Sell signal.

Amicus (FOLD) Technical Indicators

Apr 26, 2025, 06:26 PM
Name
Value
Implied Action
RSI (14)
46.28
Neutral
STOCH (9,6)
92.22
Sell
STOCHRSI (14)
64.40
Neutral
MACD (12,26)
-0.39
Sell
ADX (14)
50.39
Sell
Williams %R
-14.18
Sell
CCI (14)
6.79
Neutral
ATR (14)
0.35
-
Ultimate Oscillator
57.75
Neutral
ROC
-2.00
Sell
Amicus Therapeutics’s (FOLD) Relative Strength Index (RSI) is 46.28, creating a Neutral signal.
Amicus Therapeutics’s (FOLD) Trend Strength Indicator (ADX) is 50.39, creating a Sell signal.
Amicus Therapeutics’s (FOLD) Commodity Channel Index (CCI) is 6.79, creating a Neutral signal.
Amicus Therapeutics’s (FOLD) Price Rate of Change (ROC) is -2.00, creating a Sell signal.

FAQ

Is FOLD a Buy, Hold, or Sell?
Based on FOLD’s technical indicators, FOLD is a Sell.
    What is FOLD’s RSI (14)?
    FOLD’s RSI (14) is 46.28, which suggests FOLD is a Neutral.
      What is FOLD’s MACD?
      FOLD’s MACD is -0.39, which suggests FOLD is a Sell.
        What is FOLD’s 5-day moving average?
        FOLD’s 5-day moving average is 7.05, which suggests FOLD is a Buy.
          What is FOLD’s 20-day moving average?
          FOLD 20-day moving average is 7.21, which suggests FOLD is a Buy.
            What is FOLD’s 50-day moving average?
            FOLD’s 50-day moving average is 8.33, which suggests FOLD is a Sell.
              What is FOLD’s 200-day moving average?
              FOLD’s 200-day moving average is 9.93, which suggests FOLD is a Sell.
                What is FOLD’s Williams % R (14)?
                FOLD’s Williams % R (14) is -14.18, which suggests FOLD is a Sell.
                  What is FOLD’s CCI (14)?
                  FOLD’s CCI (14) is 6.79, which suggests FOLD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis